Methylphenidate Hydrochloride Extended Release Capsule: Clinical Trials

2 trials of Methylphenidate Hydrochloride Extended Release Capsule, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1
Phase 41Recruiting 1

Follow Methylphenidate Hydrochloride Extended Release Capsule: new trials by email Literature Review of Methylphenidate Hydrochloride Extended Release Capsule trials Research Report on Methylphenidate Hydrochloride Extended Release Capsule

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
Methylphenidate Hydrochloride Extended Release Capsule - Attention-deficit/Hyperactivity Disorder
Phase 4RecruitingNYU Langone Health302025-01-292026-04-29
Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting
Methylphenidate Hydrochloride Extended Release Capsule, Placebo - Attention Deficit Hyperactivity Disorder, ADHD
Phase 3CompletedRhodes Pharmaceuticals, L.P.262011-01-192022-12-13

Conditions studied

Attention Deficit Disorder with Hyperactivity (2)  ·  Impulsive Behavior (1)  ·  Spasm (1)

Sponsors

NYU Langone Health (1)  ·  Rhodes Pharmaceuticals, L.P. (1)

Countries

United States (2)

Top investigators

Lenard Adler, MD (1)  ·  Robert Kupper, Ph.D. (1)  ·  Sharon B. Wigal, Ph.D. (1)  ·  Wei-wei Chang, Ph.D. (1)

Results publications

PMID 25470572